Lensar (LNSR) Income towards Parent Company (2019 - 2026)
Lensar (LNSR) posted quarterly Income towards Parent Company of -$42000.0 for Q1 2026, up 99.81% year-over-year from -$21020.0 in Q1 2025, and up 99.19% quarter-over-quarter from -$5.2 million in Q4 2025.
Lensar (LNSR) Income towards Parent Company (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Income towards Parent Company for 8 consecutive years, with -$42000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company rose 99.81% year-over-year to -$42000.0; the TTM figure through Mar 2026 stood at -$46.6 million (down 34.12% YoY), while the FY2025 annual figure was -$36.2 million, down 106.41% from the prior year.
- Income towards Parent Company grew to -$42000.0 in Q1 2026 per LNSR's latest filing, from -$5.2 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$42000.0 in Q1 2026 and bottomed at -$22.1 million in Q1 2025.
- Historically, Income towards Parent Company has averaged -$8.7 million across 5 years, with a median of -$7.3 million in 2023.
- Annual changes were most pronounced in 2025 — Income towards Parent Company slumped 539.88% — and 2026, when it jumped 99.81%.
- Lensar's Income towards Parent Company stood at -$2.7 million in 2022, then decreased by 24.04% to -$3.4 million in 2023, then advanced by 13.13% to -$2.9 million in 2024, then tumbled by 75.14% to -$5.2 million in 2025, then jumped by 99.19% to -$42000.0 in 2026.
- Business Quant data shows LNSR's Income towards Parent Company at -$42000.0 in Q1 2026, -$5.2 million in Q4 2025, and -$20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Lensar | 105.26 Mn | 91.70 Mn | 9.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114,000.00 |
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | -5.16 Mn |
| Sep 30, 2025 | -20.59 Mn |
| Jun 30, 2025 | -20.85 Mn |
| Mar 31, 2025 | -22.12 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Sep 30, 2024 | -3.22 Mn |
| Jun 30, 2024 | -6.48 Mn |
| Mar 31, 2024 | -7.27 Mn |
| Dec 31, 2023 | -3.39 Mn |
| Sep 30, 2023 | -7.26 Mn |
| Jun 30, 2023 | -4.08 Mn |
| Mar 31, 2023 | -9.54 Mn |
| Dec 31, 2022 | -2.73 Mn |
| Sep 30, 2022 | -10.27 Mn |
| Jun 30, 2022 | -11.14 Mn |
| Mar 31, 2022 | -11.03 Mn |
| Dec 31, 2021 | -4.43 Mn |
| Sep 30, 2021 | -11.57 Mn |